Vitamin Shoppe, a leading specialty retailer and direct marketer of nutritional supplements, raised $155 million by offering 9.1 million shares at $17 each, above the $14-$16 range, on Tuesday. The stock is expected to begin trading on the NYSE under the symbol "VSI" on Wednesday. JPMorgan, BofA Merrill Lynch and Barclays were the bookrunners on the deal.
